Subscribe To
Waste connections: pricing power, margin improvement initiatives drive a positive business outlook
Despite a decline in volume, WCN reported strong 2Q23 results with impressive price increases outpacing competitors. WCN's focus on shedding low-margi...
September 12, 2023, 12:21 am
arrowhead: biotech innovation on display
arrowhead is a promising biotech company with a strong platform and pipeline of drugs targeting various...
June 6, 2023, 11:55 am
Salona global closes acquisition of arrowhead medical, provides update on biodex integration; posts first quarter results with positive adjusted ebitda, 23% annual revenue growth and 27% growth in ann
SAN DIEGO, May 16, 2023 (GLOBE NEWSWIRE) — Salona Global Medical Device Corporation (“Salona Global”, “SGMD” or the “Company”) (TS...
May 16, 2023, 11:30 am
arrowhead pharmaceuticals, inc. (arwr) q2 2023 earnings call transcript
arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR ) Q2 2023 Earnings Conference Call May 2, 2023 4:30 PM ET ...
May 2, 2023, 8:42 pm
arrowhead pharmaceuticals shares rise on positive interim trial results
arrowhead Pharmaceuticals has released positive interim results from its Phase 1/2 study of its investi...
April 25, 2023, 11:07 am
arrowhead pharmaceuticals to webcast fiscal 2023 second quarter results
PASADENA, Calif.--(BUSINESS WIRE)---- $arwr--arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announ...
April 18, 2023, 7:30 am
Is arrowhead pharmaceuticals a buy now?
arrowhead Pharmaceuticals recently received a rating upgrade from SVB Financial and a price target that...
April 16, 2023, 5:21 am
arrowhead pharmaceuticals to present at 43rd annual cowen health care conference
PASADENA, Calif.--(BUSINESS WIRE)---- $arwr--arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announ...
March 3, 2023, 7:30 am
arrowhead pharmaceuticals requires caution
arrowhead Pharmaceuticals, Inc. is a company with strong potential. However, it has yet to conclusively...
February 23, 2023, 2:19 pm
arrowhead pharmaceuticals, inc. (arwr) q1 2023 earnings call transcript
arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR ) Q1 2023 Earnings Conference Call February 6, 2023 4:30 P...
February 6, 2023, 9:14 pm
arrowhead pharmaceuticals to present at 41st annual j.p. morgan healthcare conference
PASADENA, Calif.--( BUSINESS WIRE )--arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that...
December 21, 2022, 4:00 pm
arrowhead pharmaceuticals: good work in progress
arrowhead is a strong biotech with unique and powerful attributes. The company has seen its share of re...
December 21, 2022, 12:29 pm
arrowhead pharmaceuticals surges after hinting at a midstage win in liver disease
arrowhead provided a bullish update for its midstage liver disease treatment on Monday, pushing ARWR st...
November 29, 2022, 12:01 pm
arrowhead pharmaceuticals, inc. (arwr) q4 2022 earnings call transcript
arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR ) Q4 2022 Earnings Conference Call November 28, 2022 4:30 ...
November 28, 2022, 8:44 pm
Royalty pharma agrees to acquire royalty interest in olpasiran from arrowhead for $250 million and future milestones
Olpasiran is an siRNA therapeutic being developed by Amgen to reduce risk of cardiovascular disease arrowhead<...
November 9, 2022, 1:49 pm
arrowhead pharmaceuticals, inc. (arwr) ceo christopher anzalone on q3 2022 results - earnings call transcript
arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR ) Q3 2022 Results Conference Call August 4, 2022 5:00 PM E...
August 4, 2022, 9:59 pm
Ncs multistage holdings, inc. (ncsm) ceo robert nipper on q2 2022 results - earnings call transcript
NCS Multistage Holdings, Inc. (NASDAQ:NCSM ) Q2 2022 Earnings Conference Call August 2, 2022 8:30 AM ET Company Participants Ryan Hummer - Chief Finan...
August 2, 2022, 9:51 am
arrowhead pharmaceuticals: an rnai name to know
Shares of RNA interference concern arrowhead Pharmaceuticals are down over 50% since making an all-time...
July 28, 2022, 3:45 pm
arrowhead pharma: we can afford to wait for more proof
arrowhead is a leader in RNAi. ARWR has a vast platform....
June 28, 2022, 11:17 am
arrowhead pharmaceuticals, inc. (arwr) ceo christopher anzalone on q2 2022 results - earnings call transcript
arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR ) Q2 2022 Earnings Conference Call May 10, 2022 4:30 PM ET...
May 10, 2022, 9:57 pm